Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (PFIZER-BIONTECH)) | PFIZER\BIONTECH | 1 | — | — |
macular degeneration to go bad; suddenly she couldn't see; tibia was infected; fluid in her ear; This is a spontaneous report received from a Consumer or other non HCP. Other Case identifier(s): 10000329006 (Genentech). An 85-year-old female patient received BNT162b2 omicron (kp.2) (COMIRNATY (2024-2025 FORMULA)), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "knee replacement" (unspecified if ongoing); "cataract surgery" (unspecified if ongoing). Concomitant medication(s) included: ADVIL [IBUPROFEN]. The following information was reported: MACULAR DEGENERATION (medically significant), outcome "unknown", described as "macular degeneration to go bad"; BLINDNESS (medically significant), outcome "unknown", described as "suddenly she couldn't see"; OSTEOMYELITIS (medically significant), outcome "unknown", described as "tibia was infected"; EAR DISORDER (non-serious), outcome "unknown", described as "fluid in her ear". Clinical course: On unknown date, patient started therapy with BioNTech Covid-19 Vaccine for unknown indication. On unknown date, it was reported that patient experienced: macular degeneration to go bad, suddenly she couldn't see. Tibia was infected, and fluid in her ear. Batch/lot number is not provided, and it cannot be obtained.
Medical History/Concurrent Conditions: Cataract operation; Knee replacement
ADVIL [IBUPROFEN]